GREENVILLE, N.C., Aug. 3, 2015 /PRNewswire/ -- ArroGen Group,
an integrated advanced forensic solutions company, will unveil its
new Fingerprint Molecular Identification™ (FMID) technology
Aug. 2-8 at the International
Association for Identification's educational conference in
Sacramento, Calif.
FMID, a new category in forensic science, will enable law
enforcement agents, district attorneys and government agencies to
build a molecular profile of criminal suspects.
By analyzing chemical residues on fingerprints taken from a
suspect or from latent prints left at crime scenes, FMID can reveal
a suspect's gender, use of tobacco, medicines and illicit drugs,
and exposure to explosives.
"FMID will give investigators, prosecutors and government
agencies a powerful new tool for human identification," said
ArroGen CEO Michael Heffernan. "This
unprecedented technology will empower their investigations and
intelligence-gathering with indisputable scientific evidence,
saving time and money."
ArroGen's patented process uses surface-engineered, silica-based
SupraNano™ powders to capture chemical residues on fingerprints and
mass spectrometry to analyze the residues.
FMID can detect gender biomarkers, nicotine use and chemicals
used in improvised explosives. It can also detect illicit drugs
such as cocaine, heroin, methamphetamines, temazepam, marijuana and
ecstasy, and legitimate medicines.
FMID for nicotine and drug use will be available in the fourth
quarter of 2015, and applications for gender and explosives will be
available in the first quarter of 2016.
ArroGen will display the FMID process and demonstrate its FMID
kits at booth 238 in the Sacramento Convention Center.
About ArroGen Group
ArroGen LLC, headquartered in Greenville, N.C., is a private company that
provides advanced forensic solutions and consulting services to
help law enforcement, attorneys, forensic laboratories, and state
and federal government agencies fight crime and terrorism.
The company provides fast, accurate biological screening and DNA
analysis at its laboratory, accredited by ISO/IEC 17025, and is
distinguished by its new human-identification technologies:
- Fingerprint Molecular Identification™ (FMID), which can analyze
residues from latent fingerprints to determine a suspect's gender,
nicotine status and exposure to explosives or drugs
- QSNP Forensic Informatics™, which can determine the individual
DNA profiles of up to five contributors to mixed DNA samples
- SupraNano™ fingerprint powders, which produce images with
higher contrast, better clarity and less background staining than
traditional powders
- SupraNano™ suspensions, which allow development of latent
fingerprints found on wet surfaces.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/arrogen-previews-new-fingerprint-molecular-identification-technology-300122571.html
SOURCE ArroGen Group